Alliance A071401: Genomically guided phase II trial of abemaciclib in patients with grade 2/3 meningiomas harboring somatic NF2 or CDK pathway alterations Meeting Abstract
| Authors: | Brastianos, P.; Dooley, K.; Geyer, S.; Gerstner, E.; Kaufmann, T.; Iafrate, A. J.; Martinez-Lage, M.; Milhem, M.; Welch, M.; Kaley, T.; Drappatz, J.; Chan, A.; Kumthekar, P.; Matsuoka, C. K.; Strowd, R.; Cohen, A.; Jaeckle, K.; Robell, L.; Magge, R.; Nam, J. Y.; Blondin, N.; Shaikh, N.; Rabinowitz, I.; Thomas, A.; Cahill, D.; Santagata, S.; Barker, F.; Galanis, E. |
| Abstract Title: | Alliance A071401: Genomically guided phase II trial of abemaciclib in patients with grade 2/3 meningiomas harboring somatic NF2 or CDK pathway alterations |
| Meeting Title: | 29th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 26 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2024 Nov 21-24 |
| Meeting Location: | Houston, TX |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-11-01 |
| Start Page: | viii21 |
| Language: | English |
| ACCESSION: | WOS:001362565900016 |
| DOI: | 10.1093/neuonc/noae165.0085 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: BIOM-12 (Citation ID: NOAE165.0085) -- Source: Wos |
